Repairing  ||| S:0 E:10 ||| NNP
Fetal  ||| S:10 E:16 ||| NNP
Membranes  ||| S:16 E:26 ||| NNP
with  ||| S:26 E:31 ||| IN
a  ||| S:31 E:33 ||| DT
Self-adhesive  ||| S:33 E:47 ||| JJ
Ultrathin  ||| S:47 E:57 ||| NNP
Polymeric  ||| S:57 E:67 ||| NNP
Film ||| S:67 E:71 ||| NNP
:  ||| S:71 E:73 ||| :
Evaluation  ||| S:73 E:84 ||| NNP
in  ||| S:84 E:87 ||| IN
Mid-gestational  ||| S:87 E:103 ||| NNP
Rabbit  ||| S:103 E:110 ||| NNP
Model  ||| S:110 E:116 ||| NNP
Preterm  ||| S:116 E:124 ||| NNP
premature  ||| S:124 E:134 ||| JJ
rupture  ||| S:134 E:142 ||| NN
of  ||| S:142 E:145 ||| IN
membranes  ||| S:145 E:155 ||| NN
causes  ||| S:155 E:162 ||| VBZ
40 ||| S:162 E:164 ||| CD
%  ||| S:164 E:166 ||| NN
of  ||| S:166 E:169 ||| IN
all  ||| S:169 E:173 ||| DT
preterm  ||| S:173 E:181 ||| JJ
births ||| S:181 E:187 ||| NNS
,  ||| S:187 E:189 ||| ,
affecting  ||| S:189 E:199 ||| VBG
150000  ||| S:199 E:206 ||| CD
women  ||| S:206 E:212 ||| NNS
each  ||| S:212 E:217 ||| DT
year  ||| S:217 E:222 ||| NN
in  ||| S:222 E:225 ||| IN
the  ||| S:225 E:229 ||| DT
United  ||| S:229 E:236 ||| NNP
States ||| S:236 E:242 ||| NNPS
.  ||| S:242 E:244 ||| .
Prenatal  ||| S:244 E:253 ||| JJ
diagnostic  ||| S:253 E:264 ||| JJ
procedures  ||| S:264 E:275 ||| NNS
and  ||| S:275 E:279 ||| CC
surgical  ||| S:279 E:288 ||| JJ
interventions  ||| S:288 E:302 ||| JJ
increase  ||| S:302 E:311 ||| NN
incidence  ||| S:311 E:321 ||| NN
of  ||| S:321 E:324 ||| IN
adverse  ||| S:324 E:332 ||| JJ
events ||| S:332 E:338 ||| NNS
,  ||| S:338 E:340 ||| ,
leading  ||| S:340 E:348 ||| VBG
to  ||| S:348 E:351 ||| TO
iatrogenic  ||| S:351 E:362 ||| VB
membrane  ||| S:362 E:371 ||| JJ
rupture  ||| S:371 E:379 ||| NN
after  ||| S:379 E:385 ||| IN
a  ||| S:385 E:387 ||| DT
fetoscopic  ||| S:387 E:398 ||| JJ
procedure  ||| S:398 E:408 ||| NN
in  ||| S:408 E:411 ||| IN
45 ||| S:411 E:413 ||| CD
%  ||| S:413 E:415 ||| NN
of  ||| S:415 E:418 ||| IN
cases ||| S:418 E:423 ||| NNS
.  ||| S:423 E:425 ||| .
We  ||| S:425 E:428 ||| PRP
propose  ||| S:428 E:436 ||| VBP
an  ||| S:436 E:439 ||| DT
ultrathin ||| S:439 E:448 ||| NN
,  ||| S:448 E:450 ||| ,
self-adherent ||| S:450 E:463 ||| NNP
,  ||| S:463 E:465 ||| ,
poly-L-lactic  ||| S:465 E:479 ||| JJ
acid  ||| S:479 E:484 ||| NN
patch  ||| S:484 E:490 ||| NN
( ||| S:490 E:491 ||| -LRB-
nanofilm ||| S:491 E:499 ||| LS
)  ||| S:499 E:501 ||| -RRB-
as  ||| S:501 E:504 ||| IN
a  ||| S:504 E:506 ||| DT
reparative  ||| S:506 E:517 ||| JJ
wound  ||| S:517 E:523 ||| NN
closure  ||| S:523 E:531 ||| NN
after  ||| S:531 E:537 ||| IN
endoscopic ||| S:537 E:547 ||| CD
/ ||| S:547 E:548 ||| CD
fetoscopic  ||| S:548 E:559 ||| CD
procedures ||| S:559 E:569 ||| NNS
.  ||| S:569 E:571 ||| .
These  ||| S:571 E:577 ||| DT
nanofilms  ||| S:577 E:587 ||| NNS
are  ||| S:587 E:591 ||| VBP
compatible  ||| S:591 E:602 ||| JJ
with  ||| S:602 E:607 ||| IN
application  ||| S:607 E:619 ||| NN
in  ||| S:619 E:622 ||| IN
wet  ||| S:622 E:626 ||| JJ
conditions  ||| S:626 E:637 ||| NNS
and  ||| S:637 E:641 ||| CC
with  ||| S:641 E:646 ||| IN
minimally  ||| S:646 E:656 ||| JJ
invasive  ||| S:656 E:665 ||| JJ
instrumentation ||| S:665 E:680 ||| NN
.  ||| S:680 E:682 ||| .
Ex  ||| S:682 E:685 ||| FW
vivo  ||| S:685 E:690 ||| FW
studies  ||| S:690 E:698 ||| NNS
to  ||| S:698 E:701 ||| TO
evaluate  ||| S:701 E:710 ||| VB
the  ||| S:710 E:714 ||| DT
nanofilm  ||| S:714 E:723 ||| NN
were  ||| S:723 E:728 ||| VBD
conducted  ||| S:728 E:738 ||| VBN
using  ||| S:738 E:744 ||| VBG
human  ||| S:744 E:750 ||| JJ
chorion-amnion  ||| S:750 E:765 ||| NN
( ||| S:765 E:766 ||| -LRB-
CA ||| S:766 E:768 ||| NNP
)  ||| S:768 E:770 ||| -RRB-
membranes ||| S:770 E:779 ||| NN
.  ||| S:779 E:781 ||| .
A  ||| S:781 E:783 ||| DT
custom-built  ||| S:783 E:796 ||| JJ
inflation  ||| S:796 E:806 ||| NN
device  ||| S:806 E:813 ||| NN
was  ||| S:813 E:817 ||| VBD
used  ||| S:817 E:822 ||| VBN
for  ||| S:822 E:826 ||| IN
mechanical  ||| S:826 E:837 ||| JJ
characterization  ||| S:837 E:854 ||| NN
of  ||| S:854 E:857 ||| IN
CA  ||| S:857 E:860 ||| NNP
membranes  ||| S:860 E:870 ||| NN
and  ||| S:870 E:874 ||| CC
for  ||| S:874 E:878 ||| IN
assessment  ||| S:878 E:889 ||| NN
of  ||| S:889 E:892 ||| IN
nanofilm  ||| S:892 E:901 ||| JJ
adhesion  ||| S:901 E:910 ||| NN
and  ||| S:910 E:914 ||| CC
sealing  ||| S:914 E:922 ||| VBG
of  ||| S:922 E:925 ||| IN
membrane  ||| S:925 E:934 ||| JJ
defects  ||| S:934 E:942 ||| NNS
up  ||| S:942 E:945 ||| RB
to  ||| S:945 E:948 ||| TO
3  ||| S:948 E:950 ||| CD
mm  ||| S:950 E:953 ||| NN
in  ||| S:953 E:956 ||| IN
size ||| S:956 E:960 ||| NN
.  ||| S:960 E:962 ||| .
These  ||| S:962 E:968 ||| DT
ex  ||| S:968 E:971 ||| JJ
vivo  ||| S:971 E:976 ||| JJ
tests  ||| S:976 E:982 ||| NNS
demonstrated  ||| S:982 E:995 ||| VBD
the  ||| S:995 E:999 ||| DT
ability  ||| S:999 E:1007 ||| NN
of  ||| S:1007 E:1010 ||| IN
the  ||| S:1010 E:1014 ||| DT
nanofilm  ||| S:1014 E:1023 ||| NN
to  ||| S:1023 E:1026 ||| TO
seal  ||| S:1026 E:1031 ||| VB
human  ||| S:1031 E:1037 ||| JJ
CA  ||| S:1037 E:1040 ||| NN
defects  ||| S:1040 E:1048 ||| NNS
ranging  ||| S:1048 E:1056 ||| VBG
in  ||| S:1056 E:1059 ||| IN
size  ||| S:1059 E:1064 ||| NN
from  ||| S:1064 E:1069 ||| IN
1  ||| S:1069 E:1071 ||| CD
to  ||| S:1071 E:1074 ||| TO
3  ||| S:1074 E:1076 ||| CD
mm  ||| S:1076 E:1079 ||| NN
in  ||| S:1079 E:1082 ||| IN
diameter ||| S:1082 E:1090 ||| NN
.  ||| S:1090 E:1092 ||| .
In  ||| S:1092 E:1095 ||| IN
vivo  ||| S:1095 E:1100 ||| JJ
survival  ||| S:1100 E:1109 ||| NN
studies  ||| S:1109 E:1117 ||| NNS
were  ||| S:1117 E:1122 ||| VBD
conducted  ||| S:1122 E:1132 ||| VBN
in  ||| S:1132 E:1135 ||| IN
25  ||| S:1135 E:1138 ||| CD
mid-gestational  ||| S:1138 E:1154 ||| JJ
rabbits ||| S:1154 E:1161 ||| NN
,  ||| S:1161 E:1163 ||| ,
defects  ||| S:1163 E:1171 ||| NNS
were  ||| S:1171 E:1176 ||| VBD
created  ||| S:1176 E:1184 ||| VBN
by  ||| S:1184 E:1187 ||| IN
perforating  ||| S:1187 E:1199 ||| VBG
the  ||| S:1199 E:1203 ||| DT
uterus  ||| S:1203 E:1210 ||| NN
and  ||| S:1210 E:1214 ||| CC
the  ||| S:1214 E:1218 ||| DT
CA  ||| S:1218 E:1221 ||| NNP
membranes  ||| S:1221 E:1231 ||| NN
and  ||| S:1231 E:1235 ||| CC
subsequently  ||| S:1235 E:1248 ||| RB
using  ||| S:1248 E:1254 ||| VBG
the  ||| S:1254 E:1258 ||| DT
nanofilm  ||| S:1258 E:1267 ||| NN
to  ||| S:1267 E:1270 ||| TO
seal  ||| S:1270 E:1275 ||| VB
these  ||| S:1275 E:1281 ||| DT
wounds ||| S:1281 E:1287 ||| NNS
.  ||| S:1287 E:1289 ||| .
These  ||| S:1289 E:1295 ||| DT
in  ||| S:1295 E:1298 ||| IN
vivo  ||| S:1298 E:1303 ||| JJ
studies  ||| S:1303 E:1311 ||| NNS
confirmed  ||| S:1311 E:1321 ||| VBD
the  ||| S:1321 E:1325 ||| DT
successful  ||| S:1325 E:1336 ||| JJ
sealing  ||| S:1336 E:1344 ||| NN
of  ||| S:1344 E:1347 ||| IN
defects  ||| S:1347 E:1355 ||| NNS
smaller  ||| S:1355 E:1363 ||| JJR
than  ||| S:1363 E:1368 ||| IN
3  ||| S:1368 E:1370 ||| CD
mm  ||| S:1370 E:1373 ||| FW
observed  ||| S:1373 E:1382 ||| FW
ex  ||| S:1382 E:1385 ||| FW
vivo ||| S:1385 E:1389 ||| FW
.  ||| S:1389 E:1391 ||| .
Histological  ||| S:1391 E:1404 ||| JJ
analysis  ||| S:1404 E:1413 ||| NN
of  ||| S:1413 E:1416 ||| IN
whole  ||| S:1416 E:1422 ||| JJ
harvested  ||| S:1422 E:1432 ||| NN
uteri  ||| S:1432 E:1438 ||| VBD
7  ||| S:1438 E:1440 ||| CD
days  ||| S:1440 E:1445 ||| NNS
after  ||| S:1445 E:1451 ||| IN
surgery  ||| S:1451 E:1459 ||| NN
showed  ||| S:1459 E:1466 ||| VBD
intact  ||| S:1466 E:1473 ||| JJ
uterine  ||| S:1473 E:1481 ||| JJ
walls  ||| S:1481 E:1487 ||| NNS
in  ||| S:1487 E:1490 ||| IN
59 ||| S:1490 E:1492 ||| CD
%  ||| S:1492 E:1494 ||| NN
of  ||| S:1494 E:1497 ||| IN
the  ||| S:1497 E:1501 ||| DT
nanofilm  ||| S:1501 E:1510 ||| JJ
repaired  ||| S:1510 E:1519 ||| JJ
fetuses ||| S:1519 E:1526 ||| NNS
,  ||| S:1526 E:1528 ||| ,
along  ||| S:1528 E:1534 ||| RB
with  ||| S:1534 E:1539 ||| IN
increased  ||| S:1539 E:1549 ||| JJ
uterine  ||| S:1549 E:1557 ||| JJ
size  ||| S:1557 E:1562 ||| NN
and  ||| S:1562 E:1566 ||| CC
intrauterine  ||| S:1566 E:1579 ||| JJ
development  ||| S:1579 E:1591 ||| NN
in  ||| S:1591 E:1594 ||| IN
63 ||| S:1594 E:1596 ||| CD
%  ||| S:1596 E:1598 ||| NN
of  ||| S:1598 E:1601 ||| IN
the  ||| S:1601 E:1605 ||| DT
cases ||| S:1605 E:1610 ||| NNS
.  ||| S:1610 E:1612 ||| .
In  ||| S:1612 E:1615 ||| IN
summary ||| S:1615 E:1622 ||| NN
,  ||| S:1622 E:1624 ||| ,
we  ||| S:1624 E:1627 ||| PRP
have  ||| S:1627 E:1632 ||| VBP
developed  ||| S:1632 E:1642 ||| VBN
an  ||| S:1642 E:1645 ||| DT
ultrathin ||| S:1645 E:1654 ||| NN
,  ||| S:1654 E:1656 ||| ,
self-adhesive  ||| S:1656 E:1670 ||| JJ
nanofilm  ||| S:1670 E:1679 ||| NN
for  ||| S:1679 E:1683 ||| IN
repair  ||| S:1683 E:1690 ||| NN
of  ||| S:1690 E:1693 ||| IN
uterine  ||| S:1693 E:1701 ||| JJ
membrane  ||| S:1701 E:1710 ||| JJ
defects ||| S:1710 E:1717 ||| NNS
.  ||| S:1717 E:1719 ||| .
